[HTML][HTML] Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

C Sharma, M Ganigara, C Galeotti, J Burns… - Nature Reviews …, 2021 - nature.com
Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy

G Griffin, S Shenoi, GC Hughes - Best Practice & Research Clinical …, 2020 - Elsevier
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening state of immune
hyperactivation that arises in the setting of genetic mutations and infectious, inflammatory, or …

Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2

C Diorio, SE Henrickson, LA Vella… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Initial reports from the severe acute respiratory coronavirus 2 (SARS–CoV-
2) pandemic described children as being less susceptible to coronavirus disease 2019 …

Similarities and differences between the immunopathogenesis of COVID-19–related pediatric multisystem inflammatory syndrome and Kawasaki disease

A Esteve-Sole, J Anton… - The Journal of …, 2021 - Am Soc Clin Investig
Multisystem inflammatory syndrome associated with the SARS-CoV-2 pandemic has
recently been described in children (MIS-C), partially overlapping with Kawasaki disease …

Severe acute respiratory syndrome coronavirus 2 placental infection and inflammation leading to fetal distress and neonatal multi-organ failure in an asymptomatic …

S Schoenmakers, P Snijder, RM Verdijk… - Journal of the …, 2021 - academic.oup.com
Background In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection during pregnancy is not considered to be an increased risk for severe maternal …

Kawasaki disease: characteristics, diagnosis, and unusual presentations

AK Jindal, RK Pilania, A Prithvi, S Guleria… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Kawasaki disease (KD) is one of the commonest pediatric vasculitides and is
associated with a significant risk of development of coronary artery abnormalities if left …

[HTML][HTML] Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children–a cross-sectional observational study from southern India.

A Venkataraman, NP Kumar, LE Hanna, S Putlibai… - …, 2021 - thelancet.com
Background SARS-CoV-2 infection in children can present with varied clinical phenotypes
and understanding the pathogenesis is essential, to inform about the clinical trajectory and …

The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome–a systematic review

JM Krei, HJ Møller, JB Larsen - Clinical & Experimental …, 2021 - academic.oup.com
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, hyperinflammatory
disorder, characterized by multiorgan failure, fever and cytopenias. The diagnosis of HLH …

Perspective of immunopathogenesis and immunotherapies for Kawasaki disease

L Chang, HW Yang, TY Lin, KD Yang - Frontiers in Pediatrics, 2021 - frontiersin.org
Kawasaki Disease (KD) is an acute inflammatory illness that mostly occurs in children below
5 years of age, with intractable fever, mucocutaneous lesions, lymphadenopathy, and …

Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches

SB Han, SY Lee - World Journal of Pediatrics, 2020 - Springer
Background Macrophage activation syndrome (MAS) is a rare, life-threatening complication
of Kawasaki disease (KD). Early recognition and treatment of MAS are very important, but …